Nuclear medicine therapy of liver metastasis with radiolabelled spheres

Martijn E.H.M. Wagemans, Arthur J.A.T. Braat, Maarten L.J. Smits, Rutger C.G. Bruijnen, Marnix G.E.H. Lam

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

1 Citation (Scopus)

Abstract

Radioembolization, also known as selective internal radiation therapy (SIRT) or trans-arterial radioembolization (TARE), is a liver-directed therapy for hepatic malignancies. Tumors are irradiated internally through administration of radioactive microspheres into the hepatic arterial vasculature via a microcatheter. Radioembolization is mostly applied as a stand-alone treatment in salvage patients with liver-dominant disease, but has shown potential in earlier lines of therapy. The efficacy and safety of radioembolization have been established in patients with primary liver tumors such as hepatocellular carcinoma, intrahepatic cholangiocarcinoma, as well as in metastatic liver tumors, like colorectal cancer, breast cancer, neuroendocrine tumors (NET) and uveal melanoma.

Original languageEnglish
Title of host publicationNuclear Medicine and Molecular Imaging
Subtitle of host publicationVolume 1-4
PublisherElsevier
Pages117-126
Number of pages10
Volume4
ISBN (Electronic)9780128229804
ISBN (Print)9780128229606
DOIs
Publication statusPublished - 1 Jan 2022

Keywords

  • CRC
  • Holmium
  • NET
  • Radioembolization
  • SIRT
  • TARE
  • Yttrium

Fingerprint

Dive into the research topics of 'Nuclear medicine therapy of liver metastasis with radiolabelled spheres'. Together they form a unique fingerprint.

Cite this